Research has documented high rates of depression in people with spinal cord injury (SCI); however, most SCI research is conducted with predominantly male study participants. Additional research is needed on depression and depression treatment among women with SCI. Objective: Study objectives were to examine depression, correlates of depression, and depression treatment in a sample of women with SCI. Methods: The sample included 51 ethnically and racially diverse women with SCI who participated in a larger study on secondary conditions of women with diverse physical disabilities. Recruited through health clinics and community organizations in a large metropolitan area, participants completed structured interviews that included demographic and disability characteristics and measures of health and health care utilization. Results: Scores on the Beck Depression Inventory-II (BDI-II) indicated that 41% of the women had depressive symptomatology in the mild to severe range. BDI-II scores were significantly related to more severe secondary conditions, greater pain, and poorer health perceptions but not to demographic or disability variables. Nearly a third (n = 16) of the women had scores exceeding the standard cutoff for significant clinical depressive symptomatology, yet only 5 of those had received any treatment for depression in the past 3 months and only 1 had received counseling or psychotherapy. Lifelong depression treatment showed a similar pattern of predominantly pharmacologic treatment. Conclusion: Depression is a common problem for women with SCI, and many do not receive treatment, particularly psychological treatment. Disability-sensitive and affordable depression treatment must be made available to women with SCI.
T
here is a large body of literature documenting the high prevalence of depression, psychological distress, and psychological morbidity after spinal cord injury (SCI). [1] [2] [3] [4] [5] [6] In a recent study of community-residing people with traumatic SCI, the rate of probable major depression was found to be 3 times that of the general population. 3 Women represent about 19% of people with SCI 7 ; therefore, most research on psychosocial health after SCI has been based on samples consisting predominantly of men with SCI. There is very little research examining rates of depression or severity of depressive symptoms specifically in women with SCI or comparing rates and severity of depression by gender. As a result, recent reviews on psychological health after SCI have been completely silent with regard to gender differences. 1, 6 Early studies seemed to confirm assumptions drawn from the literature on the general population that rates of depression were higher among women with SCI 5, 8 ; however, more recent findings have been mixed, with some studies reporting greater depression and poorer mental health among women 3, [9] [10] [11] and others finding no differences between men and women. 12, 13 Although the prevalence of depression after SCI has received a great deal of attention in the literature, a number of researchers have argued that more research needs to be directed toward the development and evaluation of effective depression treatments for people with SCI. [2] [3] [4] [5] [6] 14, 15 There is little known about the treatment that people with SCI receive for depression. Noting this lack of research about treatment, particularly the application of standard treatment guidelines for depression among people with SCI, 16 Fann and colleagues 3 examined depression treatment utilization of people with SCI. They found low rates of mental health treatment for people with SCI who had probable major depression. Among those classified as depressed in their sample, only 29% were receiving antidepressant medication and far fewer were receiving medication at an appropriate guideline-level dosage and duration. Only 11% had received any psychotherapy for depression in the past 3 months, and only half of these had received appropriate guidelinelevel psychotherapy in the past 3 months. To our knowledge, this is the only study in the literature examining and documenting lower rates of depression treatment among people with SCI. Gender and gender differences received little attention in the article, but an examination of the tables revealed that a higher percentage of women than men had elevated depression scores. The authors did note that results not included in the article revealed a trend toward women receiving more guideline-level treatment than men. No such gender differences were noted with regard to whether participants received any treatment for depression.
Given the paucity of data on depression treatment among women with SCI, the purpose of this study was to examine depression and its treatment in a sample of women with SCI. Using a self-report interview survey, the study examined depressive symptomatology and recent as well as lifetime treatment for depression. In addition, demographic, disability, and health-related variables were examined as potential correlates of depression in an effort to identify important factors for clinicians to consider in screening for and treating depression in women with SCI.
Methods

Sample
The sample consisted of 51 women with SCI from a larger study on the cost of secondary conditions of women with diverse physical disabilities. The sample was recruited through public and private clinics and community organizations in a large metropolitan area. Women were eligible to participate in the study if they were at least 18 years of age, spoke either English or Spanish, and selfidentified as having a diagnosis, for at least 1 year, of a physical disability or health condition that limited one or more major life activities. Women were excluded from the study if they reported suicidal intentions, were currently abusing alcohol or other drugs, had no telephone at which they could be reached, or did not live in or planned to move from the metropolitan area within the next 12 months. The larger study consisted of bimonthly telephone interviews conducted over the course of a year; however, the data reported here represent time 1 data only. To be included in the subsample of women included in the current analyses, participants were required to identify SCI as their primary disability.
The sample was diverse in terms of age, race/ ethnicity, and education (see Table 1 ), although the majority of the women were unemployed and most were not married. There was a wide range in income; however, the median personal and household incomes were quite low. There were more women in the sample with paraplegia than tetraplegia, and most of the women had been living with their disability for more than a decade (mean [SD] disability duration = 12.64 [12. 71] years; range, 1-42 years).
Measures
Data were collected by means of a survey questionnaire that was administered in a structured interview. The survey included demographic, disability, and health-related information; a measure of depressive symptoms; and questions pertaining to recent and lifetime treatment for depression. Basic demographic information, including age, race/ethnicity, marital status, educational level, employment status, and personal and household income was collected as part of the survey. The survey also included questions pertaining to participants' SCI, including age at onset, disability duration, level of injury, and functional limitations, as measured by the 10-item Physical Function subscale of the Medical Outcomes Study Short Form-36 Health Survey (SF-36). 17 The SF-36 Physical Function subscale consists of 10 items on which participants rate the extent to which they are limited (a lot, a little, or not at all) in their ability to engage in the activity in question. Examples of items include lifting or carrying groceries and climbing one flight of stairs. Scores are transformed to range from 0 to 100, with lower scores reflecting greater physical limitations.
Health-related measures included in the survey consisted of measures of general health perceptions, bodily pain, and secondary health conditions. The General Health subscale of the SF-36 was used to assess general health perceptions. This subscale consists of 5 items asking participants to rate, on a 5-point response scale, their health in general (excellent to poor) and their agreement (definitely true to definitely false) with 4 additional statements about their overall health, their health compared to others they know, and their expectations that their health will get worse. The SF-36 Bodily Pain subscale, which consists of 2 items assessing how much bodily pain respondents have had during the past 4 weeks and how much their pain interfered with their normal work, was used to assess pain experience. Scores on both SF-36 subscales were b Median rather than mean income is presented due to the skewed distribution of this variable.
c Analysis conducted only on the 46 on whom level of injury data were available.
coded and transformed according to scoring instructions 18 such that scores range from 0 to 100, with higher scores representing better health and less pain.
The Health Conditions Checklist (HCC), a gender-sensitive adaptation of an earlier secondary conditions measure, 19 was used to assess the number and severity of secondary health conditions commonly experienced by people with physical disabilities. Respondents were asked to rate each of 42 health conditions on a scale of 0 to 3 (0 = not a problem in the previous 2 months, 1 = a mild or infrequent problem, 2 = a moderate or occasional problem, and 3 = a significant or chronic problem) or indicate that they had never had this condition. Scores were summed to assess the cumulative severity of secondary conditions. Although depression is 1 of the 42 conditions included in the HCC, it was excluded from the HCC severity score in this study; thus, HCC severity scores, based on the 41 remaining items, could range from 0 to 123.
Symptoms of depression were assessed using the Beck Depression Inventory-Second Edition (BDI-II). 20 The BDI-II is a self-report screening measure consisting of 21 items assessing depression severity. Each item consists of a list of 4 statements arranged in increasing severity about a specific symptom of depression experienced over the past 2 weeks. Scores on individual items range from 0 to 3, with total scores ranging from 0 to 63. The symptom content of the BDI-II corresponds to the diagnostic criteria for major depressive disorder as generated by the Diagnostic and Statistical Manual of Mental Disorders. 21 Beck and colleagues 20 have suggested the following cut scores and interpretive labels to characterize scores on the BDI-II: minimal (0-13), mild (14) (15) (16) (17) (18) (19) , moderate (20) (21) (22) (23) (24) (25) (26) (27) (28) , and severe (29-63) depression. They also recommended that a cut point of 17 or greater be used to identify research samples with clinically significant depressive symptomatology.
Finally, participants were asked if they had ever received treatment for depression. If they had, they were asked to indicate if they had received outpatient psychotherapy or counseling, had received medication, or had been hospitalized for depression. Participants were then asked if they had received any treatment for depression within the past 3 months. Those who indicated they had received treatment within the past 3 months were asked if they were currently receiving medication for depression and if they were currently receiving psychotherapy or counseling for depression.
Planned statistical analyses
Descriptive statistics were calculated to summarize the severity of depressive symptoms, the number and percentage of women reporting depression scores exceeding standard cut points on the BDI-II, and the number and percentage reporting lifetime and recent treatment for depression. To examine the relation between BDI-II scores and continuous demographic, disability, and health-related variables, Pearson correlations were calculated. For categorical variables, t tests and analysis of variance (ANOVA) were conducted. Given the relatively small sample of women with SCI, several demographic and disability-related variables were collapsed for these analyses. Marital status, employment status, and race/ethnicity were all represented by dichotomous variables reflecting those who were married or were in a marriagelike relationship versus those who were not, those employed versus those unemployed, and those who were White non-Hispanic versus all other racial and ethnic groups combined, respectively. Level of education was collapsed into 3 groups (completed high school and completed less than high school combined, completed some education post high school, and completed college degree or additional postcollege education). Because personal and household incomes were significantly skewed, these data were transformed (log 10 ) prior to examining the relation between income and BDI-II scores.
Results
The mean (SD) score on the BDI-II in this sample of women with SCI was 12.02 (9.59). Although the majority of women did not have depression scores indicative of a major depressive disorder, more than 40% (n = 21) of the women in the sample had scores in the mildly depressed range or higher, with nearly a quarter (n = 12) scoring in the moderately or severely depressed range (see Table 2 ). depression scores were significantly related to marital status, such that women who were not married had significantly lower BDI-II depression scores than women who were married or in a marriage-like relationship [M (SD) = 9.94 (8.66) vs 15.83 (10.27), for nonmarried and married women, respectively]. No other demographic variables were significantly related to BDI-II scores (see Table 1 ). Similarly, no disability variables were significantly related to depression, including level of injury, age of injury, disability duration, and physical function. Depression scores were more strongly related to the 3 health-related variables (secondary conditions, bodily pain, and general health perceptions) than the demographic and disability-related variables. Results indicated that more secondary conditions, greater pain, and poorer health perceptions were related to greater depressive symptomatology. After applying a Bonferroni correction to reduce the likelihood of Type I errors by adjusting the critical P value for each individual significance test (required P value = .0036), only the SF-36 General Health subscale was statistically significant.
Discussion
Depression scores of the women with SCI participating in this study, on average, were elevated, with nearly a third of the women's scores exceeding the standard cutoff for significant depressive symptomatology on the BDI-II. The
In the current sample of women with SCI, 16 women (31%) exceeded the cut point of 17 that has been recommended for use when screening for clinically significant depressive symptomatology. However, only 5 of these women reported receiving treatment for depression within the past 3 months. All 5 receiving treatment reported pharmacologic treatment for depression; only one woman reported receiving counseling or psychotherapy.
When the full sample of 51 women with SCI was asked about lifetime treatment of depression, a similar pattern was observed. Nearly 40% of the women (n = 20) reported receiving some treatment for depression during their lifetime; however, the majority of the women reporting any lifetime treatment (n = 13; 65%) indicated that they had received only pharmacologic treatment. About a third of those women (n = 7; 35%) reported having received both pharmacologic treatment and psychotherapy/counseling in their lifetimes. None of the women in this sample reported having ever received inpatient treatment for depression.
A final objective of this article was to examine correlates of depression to support researchers and clinicians in their efforts to (a) identify women with SCI who are at risk for depression and (b) develop effective interventions for depression that address the unique needs of women with SCI. As noted previously, we examined the relation between BDI-II scores and available demographic, disability, and health-related variables using Pearson correlations, t tests, and ANOVAs. BDI-II Of serious concern was the finding that most of the women with elevated BDI-II scores were not receiving any treatment for depression. Less than a third had received any treatment for depression in the past 3 months, and such treatment was almost exclusively pharmacologic treatment. The examination of the lifetime history of depression treatment resulted in similar findings, with most depression treatment limited to medication. These results suggest the need for health care providers to be more proactive in assessing and treating depression in women with SCI. Although most women with SCI may not experience significant depressive symptoms, a sizeable number of women do experience clinically significant depression, and our data suggest that they do not receive adequate treatment. A recent study using a large national dataset of community adults 18 years old or older living in the United States 23 revealed that most respondents with a mood disorder had not seen a professional within the previous 12 months. Although the percentage of people seeking and obtaining treatment appears similar to our findings on the surface (37.8% with major depression and 44.5% with dysthymia had received some professional help), the percentages in the national survey varied greatly by gender. Women, particularly middle-aged women, were far more likely to have seen a professional and received some treatment, with treatment rates estimated at 74.4% and 74.9% for women with major depression and dysthymia, respectively. Other studies have similarly found that treatment rates for depression are significantly higher for women than men. 24 Given that our sample consisted only of women, the treatment rates reported in this study are strikingly low.
A recent study of women receiving chemotherapy for breast cancer 25 revealed that 66.7% of the women in that study who were experiencing clinically significant depression had received evidence-based treatment for depression (defined as antidepressant medication or psychotherapy from a psychiatrist or psychologist) within the past 3 months. In stark contrast to our findings, the majority of the women in that study were receiving individual psychotherapy or a combination of individual psychotherapy and pharmacotherapy. Given the literature documenting that a combination of medication and psychotherapy provides the most efficacious treatment, 26 the small percentage of women with SCI receiving psychotherapy or counseling for depression suggests that most depressed women with SCI may not be receiving the full complement of treatment they need.
There are likely many reasons for the inadequate treatment of depressive symptoms in our sample of women with SCI. First, depression may not be adequately recognized or diagnosed. Factors that may contribute to underdetection and underdiagnosis include a failure to recognize common secondary conditions, such as fatigue and sleep disturbance, as symptoms of depression. Such symptoms, which are commonly experienced by people with SCI, can mask an underlying mood disorder. Underdiagnosis can also result from an expectation of patients, families, and health care professionals that depression is an expected or understandable response to SCI. In addition, the occurrence of serious medical concerns, issues, and complications may result in health care providers prioritizing pressing medical complications and failing to diagnosis and address psychological health issues. The very low participation in psychotherapy found in this study may be related to the tremendous barriers people with SCI experience in accessing health care services. Due to disparities in employment, people with SCI may lack the financial resources and insurance coverage to access psychotherapy services. In addition, there may not be mental health care providers available who have expertise or who are informed about depression in the context of disability. Finally, transportation and environmental barriers can make it difficult or impossible for people with SCI to access services. Although stigma and a reluctance to acknowledge depression can be a barrier to receiving health care services, research suggests that such stigma is more prevalent among men than women. 27 The extent to which the factors noted above contribute to underdiagnosis and undertreatment of mental health disorders among men and women with SCI are not well understood. Additional research is needed to better understand factors contributing to undertreatment, especially given recent findings indicating that depression not only affects quality of life but also increases risk of health conditions such as cardiovascular disease, stroke, and diabetes. 28 The results of this study contribute to our understanding of who may be at higher risk of experiencing depressive symptoms. An examination of the correlates of depressive symptoms in this sample suggests that the greatest risk factors for depression among women with SCI are health related. Although only general health was significantly related to depression scores after applying a Bonferroni correction, this procedure has been criticized for dramatically increasing the likelihood of Type II errors, 29 especially when applied to smaller samples. It is important to point out that the strength of the correlation between depression scores and pain (r = -.29) and secondary health conditions (r = .31) indicates a moderate effect size or a moderate relation between depression and these 2 health-related variables. 30 Using those same guidelines, 29 the correlation between depression score and general health (r = .5) indicates a strong relation. Women who reported poorer health perceptions and more severe secondary health conditions, including pain, had higher depression scores. It may be particularly important for health care providers to consider and screen for depression among their patients who are experiencing pain and poor health, a group for which differentiating somatic symptoms of depression from poor health and disability can be especially challenging.
The fact that disability-related variables, including severity of limitations and level of injury, were not related to depression scores is consistent with a recent literature review on psychosocial issues in SCI. 6 We found that women with SCI who were married or in marriage-like relationships had higher depression scores on average than women who were not in a marriage-like relationship. This finding runs counter to findings in the general population. 31 Although caution is advised in drawing conclusions from such a small sample, this finding corroborates recent studies suggesting that marriage does not necessarily enhance quality of life in the first 6 months of injury 32 or well-being in women 33 after SCI. There are a number of limitations to this study, including the small sample size and the limited information available on the nature and extent of depression treatment. In addition, the crosssectional nature of the data makes it impossible to examine or determine causality. Nonetheless, this study offers a brief glimpse into the treatment of depression among a sample of women with SCI, a population that has received inadequate attention in the male-dominated literature on SCI. This study suggests that, although not normative, depression among women with SCI is a frequent threat to well-being that may be underdiagnosed and undertreated, particularly with nonpharmacologic treatments.
More needs to be done by health care providers to assess, diagnose, and treat depression among women with SCI. Pain and poor health appear to be contributors to depression in our sample, suggesting that health care providers attending to the medical needs of women with SCI are in an ideal position to screen, identify, and provide referrals to women with SCI who are experiencing significant depression. There are a number of preventable obstacles to receiving treatment for depression, including cost, environmental barriers limiting access to in-person psychotherapy, and attitudinal barriers suggesting that depression is an expected or normative response to SCI or that psychosocial issues are a lower priority treatment consideration. We must challenge and work to address such barriers. It is imperative that we apply existing depression programs created for women with physical disabilities 34 to this population, develop affordable SCI-specific depression treatment programs, and strive to make such treatments accessible and available to women with SCI.
Conclusion
These results suggest that clinically significant depressive symptoms are common among women with SCI. Women with SCI who experienced more secondary conditions, greater pain, and poorer general health reported more depressive symptoms. Depression appears to frequently go untreated; when treatment is received, it is likely to be limited to pharmacologic treatment. More needs to be done by health care providers to assess, diagnose, and treat depression among women with SCI. Disability-sensitive and affordable treatment needs to be made available to women with SCI.
